Quick Answer
BICYCLE THERAPEUTICS PLC reported Cash and Equivalents of $628.11 million for fiscal year 2025.
BICYCLE THERAPEUTICS PLC Cash and Equivalents — Annual History
| Fiscal Year | Cash and Equivalents | YoY Change |
|---|---|---|
| 2025 | $628.11M | -28.6% |
| 2024 | $879.52M | +67.1% |
| 2023 | $526.42M | +55.2% |
| 2022 | $339.15M | -22.7% |
| 2021 | $438.68M | — |
Quarterly Cash and Equivalents
| Quarter Ending | Cash and Equivalents | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $648.33M | -27.2% | -10.1% |
| June 30, 2025 | $721.45M | -25.0% | -9.0% |
| March 31, 2025 | $792.97M | +73.5% | -9.8% |
| December 31, 2024 | $879.52M | +67.1% | -1.3% |
| September 30, 2024 | $890.86M | +55.7% | -7.3% |
| June 30, 2024 | $961.36M | +182.4% | +110.4% |
| March 31, 2024 | $457.00M | +55.5% | -13.2% |
| December 31, 2023 | $526.42M | +55.2% | -8.0% |
- BICYCLE THERAPEUTICS PLC showed a decrease of -28.6% in Cash and Equivalents compared to the prior fiscal year.
- Over the 2021–2025 period, BICYCLE THERAPEUTICS PLC’s cash and equivalents has grown by 43.2% (from $438.68 million to $628.11 million).
- The most recent figure is from BICYCLE THERAPEUTICS PLC’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 17, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: